RxDoctor Payments Data

Barbara Lynch

Family · Mount Vernon, NYNPI 1902225881

Payments from drug & device makers

$9,945in general payments, 2019–2025

Across 399 payments — averaging $24.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • GSK$819
  • Novo Nordisk$723
  • Lilly USA, LLC$696
  • Johnson & Johnson$673
  • plus $4K from 27 others

What the payments were for

  • Food & beverage$9,71198%
  • Education$2342%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,945 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.

See all family providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin20$14,383
Albuterol Sulfate HfaAlbuterol Sulfate13$496
Metoprolol Succinate25$445
Rosuvastatin Calcium20$354
Atorvastatin Calcium45$278
Levothyroxine Sodium43$234
Amlodipine Besylate92$219
Metformin Hcl43$180
Losartan Potassium42$155
Omeprazole18$130
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide15$125
Hydrochlorothiazide57$123
Tamsulosin Hcl15$115
Lisinopril25$94
Simvastatin49$86

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$558$14,38320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,883 family providers in New York.

Other family in Mount Vernon

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →